PODCAST · business
Regulatory: The Emerging C-Suite Leader
by SSI Strategy
Welcome to Regulatory: The Emerging C-Suite Leader — the podcast where regulatory isn’t just a checklist. It’s leadership. Hosted by Debra Aub Webster and Trevor Mill — two of our Chief Regulatory Officers — this show goes behind the scenes of biotech’s highest-stakes decisions. From FDA meetings that define the future of a company to global strategies that set the pace for clinical success, we explore how regulatory thinking becomes strategic advantage. Each episode features candid conversations with seasoned leaders who’ve navigated accelerated programs, first-in-human trials, and critical inflection points. These are the lessons you won’t find in a training deck. If you're a biotech executive, investor, or regulatory leader, this podcast is for you. Because regulatory affairs isn’t just about approval — it’s about direction.
-
3
Regulatory Strategy for Accelerated Programs
Murray Abramson, Chief Development Officer at Ascidian, explores what it takes to accelerate drug development in complex settings, particularly in diseases with limited patient populations.
-
2
Building the Investor Narrative
Rami Rahal, an investor at a leading biotech investment firm with a background spanning genetic research, brings a practical lens on what makes a biotech company fundable.
-
1
From Preclinical to Proof of Concept: FIH Challenges
Gilmore O’Neill, neurologist and CEO of Editas, unpacks what strong regulatory leadership looks like when a biotech is racing toward first-in-human (FIH) and proof of concept.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Welcome to Regulatory: The Emerging C-Suite Leader — the podcast where regulatory isn’t just a checklist. It’s leadership. Hosted by Debra Aub Webster and Trevor Mill — two of our Chief Regulatory Officers — this show goes behind the scenes of biotech’s highest-stakes decisions. From FDA meetings that define the future of a company to global strategies that set the pace for clinical success, we explore how regulatory thinking becomes strategic advantage. Each episode features candid conversations with seasoned leaders who’ve navigated accelerated programs, first-in-human trials, and critical inflection points. These are the lessons you won’t find in a training deck. If you're a biotech executive, investor, or regulatory leader, this podcast is for you. Because regulatory affairs isn’t just about approval — it’s about direction.
HOSTED BY
SSI Strategy
Loading similar podcasts...